RFID’s Possible Interaction With Biologics Queried By Biogen, Pfizer

Radiofrequency identification appears to hold the most potential to increase the security of the pharmaceutical supply chain, stakeholders advise FDA, but important questions include how the radiofrequency emissions might interact with biologics and certain other kinds of drug products

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet